Multimarker proteomic profiling for the prediction of cardiovascular mortality in patients with chronic heart failure

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Lemesle, Gilles ^a,b,c,d   Maury, Fleur ^a,b,d   Beseme, Olivia ^a,b,c   Ovart, Lionel ^a,b,d   Amouyel, Philippe ^a,b,c,d   Lamblin, Nicolas ^a,b,c,d   De Groote, Pascal ^a,b,c,d   Bauters, Christophe ^a,b,c,d   Pinet, Florence ^a,b,c  

^a Univ Lille   (France)

^b Nstitut Pasteur de Lille   (France)

^c UNIV LILLE   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE; BIOLOGICAL MARKER; PROTEOME;

ADULT; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; PREDICTION; PROTEIN ANALYSIS; PROTEOMICS; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; VALIDATION STUDY; CARDIOVASCULAR SYSTEM; CHRONIC DISEASE; HEART LEFT VENTRICLE FUNCTION; HEART TRANSPLANTATION; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PHYSIOLOGY; PROCEDURES; RISK FACTOR;

BIOMARKERS; CARDIOVASCULAR SYSTEM; CHRONIC DISEASE; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PROTEOME; PROTEOMICS; RISK ASSESSMENT; RISK FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 84929377257     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119265     Document Type: Article

References (28)

1. Hoes AW, Mosterd A, Grobbee DE. An epidemic of heart failure? Recent evidence from Europe. Eur Heart J. 1998; 19 Suppl L: L2-9. PMID: 9821002
2. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007; 93: 1137-1146. PMID: 17699180
3. Jhund PS, Macintyre K, Simpson CR, Lewsey JD, Stewart S, Redpath A, et al. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation 2009; 119: 515-523. doi: 10.1161/CIRCULATIONAHA.108.812172 PMID: 19153268
4. Cintron G, Johnson G, Francis G, Cobb F, Cohn JN. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 1993; 87: VI17-23. PMID: 8500235
5. Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000; 102: 203-210. PMID: 10889132
6. de Groote P, Dagorn J, Soudan B, Lamblin N, McFadden E, Bauters C. B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure. J Am Coll Cardiol. 2004; 43: 1584-1589. PMID: 15120815
7. Rahimi K, Bennett D, Conrad N, Williams TM, Basu J, Dwight J, et al. Risk prediction in patients with heart failure: a systematic review and analysis. JACC Heart Fail. 2014; 2: 440-446. doi: 10.1016/j.jchf.2014.04.008 PMID: 25194291
8. Ouwerkerk W, Voors AA, Zwinderman AH. Factors Influencing the Predictive Power of Models for Predicting Mortality and/or Heart Failure Hospitalization in Patients With Heart Failure. JACC Heart Fail. 2014; 2: 429-436. doi: 10.1016/j.jchf.2014.04.006 PMID: 25194294
9. Dubois E, Fertin M, Burdese J, Amouyel P, Bauters C, Pinet F. Cardiovascular proteomics: translational studies to develop novel biomarkers in heart failure and left ventricular remodeling. Proteomics Clin Appl. 2011; 5: 57-66. doi: 10.1002/prca.201000056 PMID: 21246740
10. Motiwala SR, Sarma A, Januzzi JL, O'Donoghue ML. Biomarkers in ACS and heart failure: should men and women be interpreted differently? Clin Chem. 2014; 60: 35-43. doi: 10.1373/clinchem.2013.202531 PMID: 24255075
11. Fertin M, Beseme O, Duban S, Amouyel P, Bauters C, Pinet F. Deep plasma proteomic analysis of patients with left ventricular remodeling after a first myocardial infarction. Proteomics Clin Appl. 2010; 4: 654-673. doi: 10.1002/prca.200900178 PMID: 21137084
12. De Groote P, Lamblin N, Mouquet F, Plichon D, McFadden E, Van Belle E, et al. Impact of diabetes mellitus on long-term survival in patients with congestive heart failure. Eur Heart J. 2004; 25: 656-662. PMID: 15084370
13. de Groote P, Fertin M, Goeminne C, Petyt G, Peyrot S, Foucher-Hossein C, et al. Right ventricular systolic function for risk stratification in patients with stable left ventricular systolic dysfunction: comparison of radionuclide angiography to echoDoppler parameters. Eur Heart J. 2012; 33: 2672-2679. doi: 10.1093/eurheartj/ehs080 PMID: 22453651
14. de Groote P, Fertin M, Duva Pentiah A, Goeminne C, Lamblin N, Bauters C. Long-Term Functional and Clinical Follow-Up of Patients With Heart Failure With Recovered Left Ventricular Ejection Fraction After beta-Blocker Therapy. Circ Heart Fail. 2014; 7: 434-439. doi: 10.1161/CIRCHEARTFAILURE.113.000813 PMID: 24563449
15. Guerrier L, Thulasiraman V, Castagna A, Fortis F, Lin S, Lomas L, et al. Reducing protein concentration range of biological samples using solid-phase ligand libraries. J Chromatogr B Analyt Technol Biomed Life Sci. 2006; 833: 33-40. PMID: 16455314
16. Thulasiraman V, Lin S, Gheorghiu L, Lathrop J, Lomas L, Hammond D, et al. Reduction of the concentration difference of proteins in biological liquids using a library of combinatorial ligands. Electrophoresis 2005; 26: 3561-3571. PMID: 16167368
17. Karatzoglou A, Smola A, Hornik K, Zeileis A. kernlab - An S4 Package for Kernel Methods in R. J Stat Softw. 2004; 11: 1-20.
18. Chung D, Chun H, Keles S. spls: Sparse Partial Least Squares (SPLS) Regression and Classification. 2013; Available: http://CRANR-projectorg/package = spls.
19. Friedman J, Hastie T, Tibshirani R. Regularization Paths for Generalized Linear Models via Coordinate Descent. J Stat Softw. 2010; 33: 1-22. PMID: 20808728
20. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012; 33: 1787-1847. doi: 10.1093/eurheartj/ehs104 PMID: 22611136
21. Petrik V, Saadoun S, Loosemore A, Hobbs J, Opstad KS, Sheldon J, et al. Serum alpha 2-HS glycoprotein predicts survival in patients with glioblastoma. Clin Chem. 2008; 54: 713-722. doi: 10.1373/clinchem.2007.096792 PMID: 18281421
22. Vermaat JS, van der Tweel I, Mehra N, Sleijfer S, Haanen JB, Roodhardt JM, et al. Two-protein signature of novel serological markers apolipoprotein-A2 and serum amyloid alpha predicts prognosis in patients with metastatic renal cell cancer and improves the currently used prognostic survival models. Ann Oncol. 2010; 21: 1472-1481. doi: 10.1093/annonc/mdp559 PMID: 20022911
23. Belluco C, Petricoin EF, Mammano E, Facchiano F, Ross-Rucker S, Nitti D, et al. Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancer. Ann Surg Oncol. 2007; 14: 2470-2476. PMID: 17594124
24. Nkuipou-Kenfack E, Duranton F, Gayrard N, Argiles A, Lundin U, Weinberger KM, et al. Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease. PLoS One 2014; 9: e96955. doi: 10.1371/journal.pone.0096955 PMID: 24817014
25. Hernandez B, Parnell A, Pennington SR. Why have so few proteomic biomarkers "survived" validation? (Sample size and independent validation considerations). Proteomics 2014; 14: 1587-1592. doi: 10.1002/pmic.201300377 PMID: 24737731
26. Boja ES, Rodriguez H. Mass spectrometry-based targeted quantitative proteomics: achieving sensitive and reproducible detection of proteins. Proteomics 2012; 12: 1093-1110. doi: 10.1002/pmic.201100387 PMID: 22577011
27. Peterman S, Niederkofler EE, Phillips DA, Krastins B, Kiernan UA, Tubbs KA, et al. An automated, high-throughput method for targeted quantification of intact insulin and its therapeutic analogs in human serum or plasma coupling mass spectrometric immunoassay with high resolution and accurate mass detection (MSIA-HRAM). Proteomics 2014; 14: 1445-1456. doi: 10.1002/pmic.201300300 PMID: 24668948
28. Myers J, de Souza CR, Borghi-Silva A, Guazzi M, Chase P, Bensimhon D, et al. A neural network approach to predicting outcomes in heart failure using cardiopulmonary exercise testing. Int J Cardiol. 2014; 171: 265-269. doi: 10.1016/j.ijcard.2013.12.031 PMID: 24387896